Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.32 |
| ▸ | PTGIR | P43119 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | HTR5A | P47898 | 1/20 | 0.30 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18089923 | 0.91 | LIMK1 (0.40) | LIMK1ALOX5TNKSTNKS2ROCK1 | |
| SCHEMBL18090006 | 0.89 | LIMK1 (0.31) | LIMK1 | |
| SCHEMBL18090111 | 0.89 | PRKDC (0.30) | — | |
| SCHEMBL18089939 | 0.87 | ALOX5 (0.50) | LIMK1ALOX5TNKSTNKS2ROCK1 | |
| SCHEMBL18089949 | 0.87 | ALOX5 (0.36) | LIMK1ALOX5TNKSTNKS2ROCK1 | |
| SCHEMBL18090062 | 0.86 | NPC1 (0.31) | MAPT | |
| SCHEMBL18090059 | 0.86 | NPC1 (0.31) | MAPT | |
| SCHEMBL18089938 | 0.84 | GABRP (0.33) | LIMK1ALOX5TNKSTNKS2ROCK1 | |
| SCHEMBL26238249 | 0.83 | TNKS (0.37) | LIMK1ALOX5TNKSTNKS2MAPT | |
| SCHEMBL18090093 | 0.82 | NPC1 (0.36) | LIMK1ALOX5ROCK1PTGIRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9780316-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-10-03 | — | — | US | disclosed |
| US-9780316-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-10-03 | — | — | US | disclosed |
| US-20160276604-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-22 | — | — | US | disclosed |
| US-20160276604-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276604-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RB1, LEF1, BRD1 | LIMK1 177/4885ALOX5 551/4885TNKS 2018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.